Heart valve tissue engineering: how far is the bedside from the bench?

@article{SanzGarca2015HeartVT,
  title={Heart valve tissue engineering: how far is the bedside from the bench?},
  author={Andr{\'e}s Sanz-Garc{\'i}a and Jorge Oliver-de-la-Cruz and Vicente Mirabet and Carolina Gand{\'i}a and Alejandro Villagrasa and Enrique Sodupe and Carmen Escobedo-Lucea},
  journal={Expert reviews in molecular medicine},
  year={2015},
  volume={17},
  pages={e16}
}
Heart disease, including valve pathologies, is the leading cause of death worldwide. Despite the progress made thanks to improving transplantation techniques, a perfect valve substitute has not yet been developed: once a diseased valve is replaced with current technologies, the newly implanted valve still needs to be changed some time in the future. This situation is particularly dramatic in the case of children and young adults, because of the necessity of valve growth during the patient's… CONTINUE READING

From This Paper

Topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 222 references

Heart disease and stroke statistics - 2013 update: A report from the American heart association

  • Go, A.S
  • 2013
Highly Influential
10 Excerpts

EMTinducing biomaterials for heart valve engineering: Taking cues from developmental biology

  • Sewell-Loftin, M.K
  • J Cardiovasc Transl R
  • 2011
Highly Influential
7 Excerpts

3D-Printed Hydrogel Technologies for Tissue-Engineered Heart Valves

  • Hockaday, L.A
  • 3D Printing and Additive Manufacturing
  • 2014

Aortic Valve Replacement with Decellularized Aortic Allografts: First Clinical Results

  • I Tudorache
  • Circulation 130(Suppl
  • 2014

Autologous tissue-engineered hear valve replacement

  • J. E. Mayer
  • Presented at the Scientific Sessions 2014 Chicago…
  • 2014
1 Excerpt

Similar Papers

Loading similar papers…